VX-970, selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein

Date 03 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session DNA repair targets
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Presenter Mohammed Asmal